The effects of low-dose IL-2 on Th17/Treg cell imbalance in primary biliary cholangitis mouse models

Zilong Wang,Zhicheng Liu,Jiarui Zheng,Linxiang Huang,Rui Jin,Xiaoxiao Wang,Dongbo Chen,Yandi Xie,Bo Feng
DOI: https://doi.org/10.1186/s12876-024-03176-0
2024-02-28
BMC Gastroenterology
Abstract:Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease. The imbalance of Th17/Treg cells has been reported in PBC patients. Low-dose IL-2 can alleviate disease severity through modulating CD4 + T cell subsets in patients with autoimmune diseases. Hence, the present study aimed to examine the effects and mechanism of low-dose IL-2 in PBC mouse models.
gastroenterology & hepatology
What problem does this paper attempt to address?